BioReperia is a biotechnology company that develops products for accelerating drug discovery and improving the diagnosis of cancer patients. It provides a zebrafish technology platform for evaluating efficacy and toxicity of drugs. The company also offers a precision medicine platform to enable identification of efficacious anti-cancer therapies.